Effects on the Diagnostic Accuracy of Magnetic Imaging Angiographies of the Supra-Aortic Vessels by Three Different Magnetic Resonance Contrast Agents in Patients
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00132223 |
Recruitment Status
: Unknown
Verified April 2006 by University Hospital Muenster.
Recruitment status was: Recruiting
First Posted
: August 19, 2005
Last Update Posted
: April 12, 2006
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Angiographies of the supra-aortic vessels by magnetic imaging have become common recently. So it was the purpose of this study to evaluate the imaging potential of different contrast agents.
Three contrast agents for magnetic resonance imaging are compared in angiographies of the supra-aortic arteries in a intraindividual study of 10 patients.
All applications of these contrast agents are performed with a flow of 2 ml/s. One contrast medium is applicated a second time with a reduced flow of 1 ml/s.
The angiographies of the supra-aortic vessels are evaluated by two experienced readers in a consensus reading. The signal/noise- and contrast/noise-ratio of anatomic vessel segments of the carotic and vertebral arteries are measured and compared to each other.
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Headache Epilepsy Dizziness | Drug: Contrast agent | Phase 4 |
Study Type : | Interventional (Clinical Trial) |
Enrollment : | 10 participants |
Allocation: | Non-Randomized |
Intervention Model: | Single Group Assignment |
Masking: | Single |
Primary Purpose: | Diagnostic |
Official Title: | Effects on the Diagnostic Accuracy of Magnetic Imaging Angiographies of the Supra-Aortic Vessels by Three Different Magnetic Resonance Contrast Agents in Patients With Headache and Dizziness or Epilepsy and Clinical Indication for an Angiography by Magnetic Imaging |
Study Start Date : | April 2005 |
Study Completion Date : | December 2005 |

- intensity of vessels, muscle, air
- signal/noise ratio
- contrast/nose ratio

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 60 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Headache
- Epilepsia
- Dizziness
Exclusion Criteria:
- Pregnancy
- Metal implants (e.g. pacemaker)
- Contraindication for contrast agent
- Multiple allergies

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00132223
Contact: Boris Buerke, MD | 00492518345123 | buerkeb@uni-muenster.de | |
Contact: Bernd Tombach, MD | 00492518345123 | tombach@uni-muenster.de |
Germany | |
University of Muenster, Dept. of Clinical Radiology | Recruiting |
Muenster, Germany, 48129 | |
Contact: Boris Buerke, MD 00492518345123 buerkeb@uni-muenster.de | |
Contact: Bernd Tombach 00492518345123 tombach@uni-muenster.de | |
Principal Investigator: Bernd Tombach, MD | |
Sub-Investigator: Boris Buerke, MD |
Study Chair: | Bernd Tombach, MD | University of Muenster, Dept. of Clinical Radiology |
ClinicalTrials.gov Identifier: | NCT00132223 History of Changes |
Other Study ID Numbers: |
0710/2004-IKR |
First Posted: | August 19, 2005 Key Record Dates |
Last Update Posted: | April 12, 2006 |
Last Verified: | April 2006 |
Keywords provided by University Hospital Muenster:
magnetic imaging angiography contrast agent |
signal/noise ratio contrast/noise ratio vessel |
Additional relevant MeSH terms:
Epilepsy Headache Dizziness Vertigo Brain Diseases Central Nervous System Diseases Nervous System Diseases Pain Neurologic Manifestations Signs and Symptoms Sensation Disorders Vestibular Diseases Labyrinth Diseases |
Ear Diseases Otorhinolaryngologic Diseases Glucuronyl glucosamine glycan sulfate Anticoagulants Hypolipidemic Agents Antimetabolites Molecular Mechanisms of Pharmacological Action Lipid Regulating Agents Fibrinolytic Agents Fibrin Modulating Agents Hypoglycemic Agents Physiological Effects of Drugs |